Through a strategic, non-profit agreement, Gilead will supply up to two million doses of the long-acting HIV prevention drug ...

National Treasury has allocated R753 million to the Department of Health -- under Section 16 of the Public Finance Management ...

While the National Treasury has released R700m, the Bill and Melinda Gates Foundation and the Wellcome Trust will ...

We also do home visits to make sure that the mothers take their medication on time, and to look after their babies when they ...

South Africa will be among the first countries in the world to receive doses of lenacapavir, the long-acting HIV prevention drug administered once every six months. This was announced by health ...

In early 2025, the US decision to halt foreign aid for HIV/AIDS programs triggered global concerns about a potential ...

A pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they liveThe Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) ...

The Global Fund has secured access to lenacapavir, a groundbreaking HIV prevention drug, for low and middle-income countries, ...

Re: "20-baht flat rate fare gets the nod", (BP, July 9). The cabinet yesterday approved a flat-rate fare of 20 baht for all ...

AIDS Healthcare Foundation (AHF) denounces Gilead Sciences for once again excluding Latin America and the Caribbean (LAC) from affordable access to a groundbreaking HIV prevention drug, lenacapavir.

Gilead Sciences (NasdaqGS:GILD) recently announced a partnership with the Global Fund to supply lenacapavir for HIV ...